SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SSP who wrote (81554)3/9/2001 11:18:22 AM
From: Jim Bishop  Read Replies (1) of 150070
 
ELTI ELAST TECHNOLOGIES INC - Unveils Bio-Potential Instrument

New York, New York, Mar 09, 2001 (Market News Publishing via COMTEX) -- ELAST
Technologies, Inc., www.elast.com announced the successful conclusion of
targeted demonstrations of its chiropractic outcome-measuring instrument --- the
Bio-Potential Instrument.

Members of the chiropractic community who observed the demonstrations were
impressed by the capabilities of the Bio-Potential Instrument, particularly its
ability to objectively measure vertebral subluxations and the normalizing effect
of chiropractic spinal adjustments.

During a series of demonstrations conducted by ELAST's Chiropractic Division
doctors of chiropractic "expressed great interest and enthusiasm in the
product," observed Thomas F. Krucker, President and CEO, "and their interest and
enthusiasm is illustrative of the immediate marketability of our Bio-Potential
Instrument." ELAST Technologies began production of its Bio-Potential Instrument
earlier this year and the Company projects to deliver initial units in the 2nd
quarter of this year.

Mr. Krucker also emphasized ELAST Technologies' continued commitment to the
perfection of its allergy testing device, the Electronic Allergo Sensitivity
Test or the ELAST Device(TM). The ELAST Device(TM) is a patented, non-invasive
diagnostic tool that is being designed to accurately diagnose allergies, as well
as food and chemical sensitivities, immediately without any of the pain or
expense associated with currently employed allergy testing methods.

This news release contains forward-looking statements. Forward-looking
statements include statements concerning plans, objectives, goals, strategies,
future events or performance and underlying assumptions and other statements
that are other than statements of historical facts. These statements are subject
to uncertainties and risks including, but not limited to, product development
and consumer demand and acceptance, changes in technology, ability to raise
capital, the availability of appropriate acquisition candidates and/or business
partnerships, economic conditions, impact of competition and pricing, capacity
and supply constraints or difficulties, government regulations and other risks.
All such forward-looking statements, whether written or oral, and whether made
by or on behalf of ELAST Technologies, Inc., are expressly qualified by these
cautionary statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, ELAST Technologies, Inc., disclaims

any obligation to update any forward-looking statement to reflect events or
circumstances after the date hereof.


CONTACT: TEL: 877/362-7832 ELAST Technologies, Las Vegas
Michael Nanry

MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041.

(C) 2001 Market News Publishing Inc.

-0-


KEYWORD: New York, New York

*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext